Full title: Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

Author/creator: Araujo, John C, Dr, Trudel, Géralyn C, PhD, Saad, Fred, Prof, Armstrong, Andrew J, MD, Yu, Evan Y, MD, Bellmunt, Joaquim, MD, Wilding, George, Prof, McCaffrey, John, Prof, Serrano, Sergio V, MD, Matveev, Vsevolod B, Prof, Efstathiou, Eleni, MD, Oudard, Stephane, Prof, Morris, Michael J, MD, Sizer, Bruce, MBChB, Goebell, Peter J, MD, Heidenreich, Axel, Prof, de Bono, Johann S, Prof, Begbie, Stephen, MBBS, Hong, Jun H, MD, Richardet, Eduardo, MD, Gallardo, Enrique, MD, Paliwal, Prashni, PhD, Durham, Susan, BA, Cheng, Shinta, MD, Logothetis, Christopher J, Prof.

Call Numbers:

Record Identifier: TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5478530

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5478530